Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks. Great info!
Ino should be in new class of stock. Bio weapons defense contractor. Details soon!
DOD and ology partnered for 267,000 doses of ino 4800. Looks like they have already been doing their own trial! Bigger than all big pharma phase 3 trials combined. I thing EUA for ino is coming sooner than we think! Along with some extensive funding....
Looks like it!
Big news over next few days including this!
The day will start with a Business Meeting from 10:00 – 10:45 am (EDT) then transition to the typical abstract presentations. Our featured speaker will be Dr. David Weiner, from the University of Pennsylvania and Wistar Institute who is leading the Inovio sponsored phase 3 DNA vaccine trial for SARS-CoV-2. He will update us on where vaccine trials stand (we all hope they will be well on the way)!
Please reserve September 26, 2020 from 10 am – 4 pm on your calendar now for the meeting. More details will follow soon.
Anyone else see the cepi update? Looks like Monday going to be some news! Not sure when though...
Started in March. Now it’s all about to be made public!
https://www.biopharma-reporter.com/Article/2020/05/18/Thermo-Fisher-to-build-viral-vector-plant?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Looks like we know when our peer review will be out!
https://www.rocketnews.com/2020/09/covid-19-a-stress-test-for-trust-in-science-the-lancet/
Montco Pharma Company's Coronavirus Vaccine Is Progressing
Inovio, a biopharmaceutical company in Montgomery County, is planning to move to Phase 2 of human trials for its coronavirus vaccine.
By Justin Heinze, Patch Staff
Sep 1, 2020 1:51 pm ET
Who!!
The first such vaccines licensed for marketing are likely to use plasmid DNA derived from bacterial cells. In future, others may use RNA or may use complexes of nucleic acid molecules and other entities. These guidelines address the production and control of vaccines based on plasmid DNA intended for use in humans. The purpose of these guidelines is to indicate:
appropriate methods for the production and control of plasmid DNA vaccines; and
specific information that should be included in submissions by manufacturers to national control authorities in support of applications for the authorization of clinical trials and marketing.
CSIRO
@CSIRO
·
3h
We have completed pre-clinical trials for both Inovio Pharmaceuticals & Oxford University. The study results are currently undergoing internal & external review, quality assurance & a compliance audit. The results will be published following this in a peer-reviewed journal
Don’t get so upset all the time stockman. We know you are short. The point is that we own part of gene one and gene one is taking off right now for some reason!
Guys check this out! Inovio/GeneOne Life Science Collaborate for Ebola Vaccine
Zacks Equity Research
September 25, 2014
Inovio Pharmaceuticals, Inc.’s (INO) shares were up 5.3% after the company announced that it will collaborate with GeneOne Life Science Inc., a company in which Inovio owns a minority stake, for the development of a DNA-based Ebola vaccine.
Gene one is up over 50 percent in past two days alone. My bet is big news leaked about ino-4800!!
https://www.bloomberg.com/quote/011000:KS
Doesn’t inovio own 10 percent or Ology also??
Ology funding just the start! Imo if they are getting 100s of millions to produce ino-4800 then inovio will be coming out very soon with billion dollar funding announcement!
Huge news broke ah with the 100 mill contract for 186 mill doses - Ology manufacturing of ino-4800. Going to be start of big things....DoD...
Yeah, next time let’s get downgraded to $50.
$88.88 for my birthday Oct 23...
I have more powder free for tomorrow if they try one last takedown before launch! I kinda hope it happens but will be ok if it doesn’t!
Next real wall at $28!
Fake wall at $21.50
Love it when this board is quiet. Means shorts are loading up!!
WHO releasing dna vaccine guidelines. Wonder if that will be good for us?
Inovio Pharmaceuticals (NASD:INO). Is a very exciting candidate for a COVID-19 Vaccine. I have interviewed two Doctors that both believe Inovio has compelling evidence the vaccine will be a success. Thus the upside could easily be above $100 a share and possibly reach $200 matching that of Moderna's (NASD:MRNA) market-cap which is valued at almost 10 x Inovio's marketcap. Novavax (NASD:NVAX) market-cap is valued 3 x greater than Invovio's and NVAX has never had a vaccine come to market.
Wow! Nice job. Will be sitting pretty!
Pretty close!
Thanks for keeping the price low. Literally tripled my share count! Going to be great Aug...
Doctor Carson on with Geraldo - 5 different vaccines currently going into phase 3!
First step my friend!
30 years!
Just the start my friend. Watch the ino-4800 news upcoming. Need to get as many prs out before our big funding is announced. Trump wants to look good giving big money to the new dna tech that will save the world! When I say new dna tech I mean new to world not to inovio. They have been working on it for over 3 years...
Great opp today to load up!
Going to see real quick what stocks are quality and been waiting to be bought!
Ino order upcoming!
Together, the Moderna, Pfizer BioNTech, AstraZeneca and Inovio trials will require at least 120,000 volunteers. Phase 2-3 baby! Announcement and funding this week imo!!!
Big breakout upcoming! Close at hod.